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Abstract
During a decade-long, high endemic situation with severe group A streptococcal disease in western Norway, a cluster of 16
patients with invasive streptococcal disease was hospitalized during a period of 11 weeks. A study including clinical characteristics
and molecular epidemiology of the outbreak was initiated. Relevant clinical information was obtained from the medical records of
the patients. Nine of the 16 patients had soft tissue infection, and seven of these had streptococcal toxic shock syndrome (STSS).
Mortality, both overall and among those with STSS, was 25%. Streptococcal isolates from these patients were characterized by se-
rogrouping and emm sequence typing. The emm amplicons were further characterized by sequence analysis and restriction fragment
length polymorphism (emm RFLP) analysis. The streptococci were identiﬁed as group A streptococcus (GAS) in 11 patients and
group G streptococcus (GGS) in four patients. The patients with GGS infection were older than the patients with GAS infection,
and all patients infected with GGS had predisposing comorbidities. Isolates from 13 patients were available for emm gene analysis
and found to belong to nine different emm types. Similar differentiation was obtained with emm RFLP in GAS. Hence, the outbreak
was polyclonal. Results suggestive of horizontal gene transfer and recombination between the emm genes of GAS, group C strep-
tococcus and GGS were found in the isolates from seven patients. Such genetic recombination events suggest a possible role in
pathogenesis.
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Introduction
Group A streptococcus (GAS) commonly causes mild infec-
tions and scarlet fever, and may also cause post-infective
sequelae. However, it can also cause life-threatening illnesses
such as necrotizing fasciitis (NF), myositis, streptococcal
toxic shock syndrome (STSS), puerperal sepsis and meningi-
tis. During the past two decades, increasing incidence and
severity of invasive GAS infections have been reported from
many countries [1–9]. A particularly high incidence of severe
soft tissue infections caused by GAS has been noted in wes-
tern Norway, where periodic outbreaks have occurred since
the late 1980s [10]. During the past few years, there has also
been an increasing number of reports of group C strepto-
coccus (GCS) and group G streptococcus (GGS) as the
cause of STSS, NF/myositis and other invasive infections
[11–15].
In February 2003, four patients with life-threatening, inva-
sive streptococcal disease were admitted to Haukeland Uni-
versity Hospital (HUH) within 8 days. This initiated a
retrospective and a prospective search for patients with
invasive disease caused by b-haemolytic streptococci. The
main objective of the study was to ﬁnd out whether the
cases were caused by closely related virulent bacterial
clones.
To gain insights into the epidemiology of this apparent
outbreak, ampliﬁcation and sequence analysis of the emm
genes from the bacterial isolates was carried out. The emm
gene codes for the M-protein, a major virulence factor with
multiple functions [16–18], and serves as an important and
useful epidemiological marker.
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Materials and Methods
Study population, case deﬁnitions and clinical parameters
HUH is a tertiary-care hospital in Bergen in western
Norway. It has a catchment area of 300 000 people as an
emergency hospital, and of 1 100 000 as a tertiary-care
hospital.
Cases were deﬁned as patients with GAS, GCS or GGS
isolated from a normally sterile site, or from a non-sterile
site in combination with clinical signs of STSS. STSS was
deﬁned using criteria originally applied to STSS caused by
GAS infections [19]. Necrotizing cellulitis and NF was
deﬁned as acute, rapidly progressing and life-threatening
destructive (i.e. necrotizing) infections of the subcutaneous
tissues dissecting along tissue planes [20].
Sixteen patients with life-threatening invasive b-haemolytic
streptococcal disease, constituting an apparent outbreak,
were included in this study. The outbreak was deﬁned by a
cluster of such cases admitted to HUH that was separated
from cases not part of the outbreak by a period of more
than 4 weeks. This study accordingly involved patients admit-
ted to this hospital with invasive streptococcal disease from
late December 2002 to early March 2003, a period of
11 weeks. A simple outbreak investigation was launched,
using genetic typing of the isolates (details shown below) and
a search for obvious geographical and other links among the
cases. No preventive measures were undertaken for con-
tacts, apart from giving treatment with penicillin to three of
the children of one patient (case no. 1, Table 1) who all had
tonsillopharyngitis with GAS.
A standard data abstraction sheet was used in the review
of the records. Age, gender, demographic information, clini-
cal diagnosis, location of infection, comorbidities and clinical
chemistry data at the time of admission and during the hos-
pital period were recorded, along with microbiological cul-
ture results, antibiotic treatment, surgery, ventilatory
support, vasopressor treatment, and the clinical outcome.
The study was approved by the ethics committee of
Health Region West of Norway.
Bacterial isolates
Clinical samples from all patients were obtained for bacterio-
logical examination. Multiple isolates from two patients were
examined, consisting of four isolates from different sites
from one patient during the acute stage, and two isolates
from another patient, the ﬁrst recovered in the acute stage
and the second during convalescence. The serogroups of the
b-haemolytic streptococci were ascertained using a rapid
latex agglutination test (Oxoid, Basingstoke, Hampshire, UK).
emm gene ampliﬁcation, sequence analysis and emm
restriction fragment length polymorphism (emm RFLP)
analysis
PCR ampliﬁcation of the emm gene was carried out essen-
tially as described previously [21]. The forward primer tar-
geted a conserved region in the leader peptide coding
sequence, and the reverse primer annealed to the coding
sequence of a conserved region at the 3¢-end of emm of
GAS. Sequencing in both directions was carried out using an
ABI Prism BigDye cycle sequencing ready reaction kit
TABLE 1. Details of 16 patients admitted in a period of 11 weeks with invasive infection due to b-hemolytic streptococci
Case
no.
Date
(month/year)
Patient age
(years), sex
Streptococcus
group, emm type
Site(s) of
isolation Clinical features STSS Antibiotics
Surgery
(no. of procedures) Outcome
1 12/02 36, M A, emm89.0 Blood Pneumonia,
cardiomyopathy, ARF
Yes PEN, CLI, GENT Yes (pleuracentesis), 1 Survived
2 12/02 72, M A, emm118.0 Blood Severe sepsis NA CTX No Died
3 12/02 40, F A Throat NF neck Yes PEN, CLI, TOBR Yes, 1 Survived
4 01/03 59, M A, emm43.4 Tissue NF leg Yes CLI, CRO, METRO Yes, 3 Survived
5 01/03 55, M A, emm87.0 Tissue NF leg Yes PEN, CLI, GENT Yes, 1 Survived
6 01/03 33, M A, emm1.0 Blood Sinusitis No ERY No Survived
7 02/03 29, M A Tissue + ulcer NF leg Yes PEN, CLI, TOBR Yes, 4 Survived
8 02/03 33, F A, emm75.0 Blood + ulcer Infectious pelvic phlebitis
with necrosis
No PEN, CLI, OXA,
GENT, METRO
Yes, 3 Survived
9 02/03 64, F A, emm89.0 Blood + abscess Diverticulitis No CEFUR Yes, 1 Survived
10 02/03 33, F A, emm89.0 Abscess NF neck No PEN, CLI, CEFUR Yes, 3 Survived
11 03/03 65, F A, emm1.0 Blood NF neck, ARF Yes PEN, CLI, GENT Yes, 5 Survived
12 12/02 76, M G, stC74a.0 Blood Venous leg ulcer No PEN, CLI No Survived
13 02/03 57, M G, stg10.0 Blood + tissue
+ throat
Necrotizing myositis leg Yes PEN, CLI, GENT Yes, 4 Died
14 03/03 63, M G, stg10.0 Blood Aortic endocarditis No CEFUR, NETIL No Died
15 03/03 49, F G, stg6.0 Blood + ulcer Vulvovaginitis No PEN, CLIN No Survived
16 01/03 24, F NA Tissue (Gram stain only) Necrotizing myositis
neck, ARF, ECMO
Yes PEN, OXA, GENT,
CEFUR, METRO
Yes, 2 Died
STSS, streptococcal toxic shock syndrome; NA, not applicable; ARF, acute renal failure; PEN, penicillin; CLI, clindamycin; GENT, gentamicin; CTX, cefotaxime; NF, necrotizing
fasciitis; TOBR, tobramycin; CRO, ceftriaxone; METRO, metronidazole; ERY, erythromycin; OXA, oxacillin; CEFUR, cefuroxime; NETIL, netilmicin; ECMO, extracorporeal
membrane oxygenation.
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(Applied Biosystems, Foster city, CA, USA), with the same
primers, and an ABI Prism 3700 DNA sequencer (Applied
Biosystems). Assignment of emm types was made using the
Streptococcus Laboratory emm type database (http://
www.cdc.gov/ncidod/biotech/strep/strepindex.htm) of the
CDC. Sequence homology to the full length of the emm
amplicons was sought using BLASTN. Polymorphism of the
whole emm amplicon was also determined by digesting the
amplicons with the restriction enzyme HindIII (New England
Biolabs, Ipswich, MA, USA) and obtaining a record of the
emm RFLP on an agarose (1%) gel.
Examination of the whole genome for clonality in an
attempt to differentiate between relapse and re-infection
DNA of the two isolates from the same patient (one isolate
cultured from blood during the acute phase, and the other
from the throat 6 weeks later) was subjected to digestion
with Sma1 (New England Biolabs) and to pulsed-ﬁeld gel
electrophoresis (PFGE).
Results
Clinical analysis and bacterial aetiology
Sixteen patients hospitalized in a period of 11 weeks were
identiﬁed. GAS was the causative organism in 11 cases and
GGS in four cases. For case 16 (Table 1), the serogroup is
not known, because the streptococcal aetiology was based on
microscopy only, where Gram stain of a deep tissue sample
taken at surgery revealed abundant bacteria with strepto-
coccal morphology. Bacteria could not be cultured from
this sample due to prior antibiotic treatment. In cases 3 and
7, only serogrouping was performed on the b-haemolytic
colonies, and the isolates were not available at a later period
for further characterization.
Table 1 gives details of the 16 patients. There were nine
men and seven women. The median age was 52 years (range
24–76 years), and there was no predominant age group. Five
patients were included retrospectively (cases 1–4 and 12).
Four of the patients were admitted within 8 days (cases 5–
8). The 16 cases were not closely clustered geographically.
No patient had his or her residence closer than 2 km to the
other patients. No other apparent connections between
cases were found.
Nine of the 16 patients had soft tissue infection. Seven of
these fulﬁlled the criteria for STSS, and GAS was the patho-
gen in ﬁve. Among the 11 patients with GAS disease, six had
NF, and one patient with glioblastoma, grade IV, died as a
result of streptococcal sepsis. One of the four GGS cases
was associated with soft tissue infection, namely, myositis in
case 13. This patient had a previously unrecognized acute
myeloid leukaemia. Overall mortality and mortality for those
with STSS were both 25%. There were no fatalities among
the cases of NF, whereas both patients with myositis died.
The median time from onset of symptoms to admission was
3.5 days for those who survived, and 2 days, 3 days, 5 days
and unknown, respectively, for the patients who died. The
time from onset of symptoms to death was 8 days, 14 days
and 15 days for the three patients with known time of debut.
All nine patients with soft tissue infection underwent surgical
debridement, including two of the four fatal cases. Only one
of the fatal cases (case 2) might not have been given optimal
treatment because of coexistent incurable malignancy. Only
one of the 11 patients who received clindamycin died,
whereas three of the ﬁve patients who did not receive clinda-
mycin died. According to established local practice, no patient
received intravenous immunoglobulin. Further clinical fea-
tures, laboratory values and predisposing factors are shown
in Table 2. Only one patient had severe acute renal failure,
TABLE 2. Clinical features, laboratory data and potential
predisposing factors concerning 16 patients, admitted
during a period of 11 weeks, with invasive infection due to
b-haemolytic streptococci
GAS
(n = 11),
no./no.
evaluated
GGS
(n = 4),
no./no.
evaluated
All cases
(n = 16),
no./no.
evaluated
Clinical features
NF/myositis 6/11 1/4 8/16
Hypotensiona 7/11 1/4 9/16
Vasopressor 5/11 0/4 6/16
Acute renal failureb,c 1/11 0/4 2/16
Mechanical ventilationb,d 5/11 1/4 7/16
STSSb 6/10 1/4 8/15
Laboratory data
Hypocapniab,e 0/6 2/2 2/9
Thrombocytopeniab,f 3/8 1/4 5/13
Hyperbilirubinaemiab,g 2/6 1/3 3/10
CRP >200 mg/Lb,h 9/11 3/4 13/16
Predisposing factor(s)
None of the factors
listed below
4/11 0/4 5/16
Cancer/chronic disease 6/11 4/4 10/16
Previous SSTI 1/11 0/4 1/16
Alcohol abuse 1/11 0/4 1/16
Drug abuse 1/11 0/4 1/16
Age ‡65 years 1/11 2/4 3/16
GAS, group A streptococcus; GGS, group G streptococcus; NF, necrotizing fas-
ciitis; STSS, streptococcal toxic shock syndrome; CRP, C-reactive protein; SSTI,
skin and soft tissue infection.
aA systolic blood pressure <90 mmHg or a reduction of ‡40 mmHg from base-
line in the absence of other causes than sepsis.
bData not available for all patients; the number of patients tested on admission
are given.
cDeﬁned as increase in serum creatinine for 2 weeks or less of 0.5 mg/dL if the
baseline is <2.5 mg/dL or an increase in serum creatinine by more than 20% if
the baseline is more than 2.5 mg/dL.
dMechanical ventilation needed not only in connection with surgery/anaesthesia;
one patient needed non-invasive ventilation only.
eArterial PCO2 <4.3 kPa.
f<100 000 thrombocytes/lL.
gTotal bilirubin >24 lmol/L.
hNormal value <5 mg/L.
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and none had disseminated intravascular coagulation. The
patients with GGS infection were older than the patients with
GAS infection (average 61 vs. 47 years, a difference not found
to be statistically signiﬁcant). All the GGS patients had predis-
posing comorbidity. Only the fatal case showed signs of organ
dysfunction. None of the 16 patients was taking non-steroidal
anti-inﬂammatory drugs at the time of admission.
Molecular epidemiology
Isolates from only 13 patients were available for genetic
characterization. emm genes were successfully ampliﬁed from
all available isolates, including the four GGS isolates. Size
variations of these emm genes were observed, and sequence-
speciﬁc subtyping by emm RFLP revealed the involvement of
at least six different clones among the nine GAS isolates
(Table 3).
Alignment analyses of the emm sequences were per-
formed both for emm typing and for recombination analysis.
Determination of emm types, based on the 150 bases encod-
ing the 50 N-terminal residues of the mature M-protein, was
relatively simple. All amplicons showed 100% identity with
sequences existing in the CDC database. It is noteworthy
that the amplicon of isolate 4 showed 100% identity with
emm43.0 in the region comprising bases 9–78, but was 100%
identical with an allele of the same emm type, namely
emm43.4, in the region comprising bases 79–228, which
determines the emm type, suggesting the probability of rec-
ombinatory events between the alleles emm43.0 and
emm43.4 in the signal peptide-encoding region.
Among the GAS isolates, each of the six different emm
RFLP types corresponded to speciﬁc emm sequence types,
thus proving RFLP typing to be a good alternative to emm
sequence typing (Table 3). As expected, the simultaneous
isolates from multiple sites from the same patient had identi-
cal emm genes, as shown by both emm sequence and emm
RFLP analysis. The acute-phase and the convalescent-phase
isolates examined for clonal relationship also proved to be
the same by emm sequence analysis and PFGE. Among the
four GGS isolates, three distinct emm types were identiﬁed.
Thus, among the 13 isolates, nine different types were found,
of which six were represented by single isolates and the
remaining three by two to three isolates.
Analysis of the full-length emm amplicons revealed mosaic
sequences in seven of the 13 patients. The results of these
analyses are schematically presented in Figs 1 and 2. It is
interesting to note that the cluster (isolates 1, 9 and 10)
TABLE 3. Size variations of the emm genes, emm RFLP
patterns (I–VI) and emm types of the nine group A
streptococcus isolates
Isolate emm size (kb) emm RFLP emm type
1 0.9 I emm89.0
2 0.9 II emm118.0
4 1 III emm43.4
5 1 IV emm87.0
6 1.2 V emm1.0
8 1 VI emm75.0
9 0.9 I emm89.0
10 0.9 I emm89.0
11 1.2 V emm1.0
emm RFLP, restriction fragment length polymorphism of the emm gene.
FIG. 1. Sequence analysis of the full-length
emm amplicons of the nine group A strepto-
coccus isolates. Reference emm sequences in
GenBank with close homology to genes/gene
segments of the analysed genes are shown
above the lines representing emm genes, along
with their capacity to produce opacity factor
(OF). The percentage of identity to these
reference sequences, along with the homolo-
gous regions, deﬁned by the base numbers,
are shown below the lines. OF+, opacity
factor-producing. OF), opacity factor-non-pro-
ducing.
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within the GAS isolates shared the same mosaic structure,
strongly suggesting that these are clonally related.
Discussion
Like many other countries, Norway has experienced an
increase in invasive GAS disease since the mid-1980s.
Although interspaced by short periods of decreased inci-
dence, a steady increase in invasive cases has been observed
since 1993 [6]. During this long-lasting endemic situation in
Norway, small outbreaks have appeared, particularly during
mid-winter. Most cases seen in such outbreaks seem to be
sporadic, and common associations between the cases have
not been reported (Norwegian Institute of Public Health;
http://www.msis.no). The incidence of invasive GAS disease
in industrialized parts of the world has been reported to
vary from 0.4 to 4.3/100 000/year [2–5,13]. During the
years 1995–2004, the incidence of microbiologically con-
ﬁrmed invasive infection with GAS, GCS and GGS was 9/
100 000/year in the region served by Haukeland University
Hospital (unpublished data from the Department of Micro-
biology). In a population of 300 000, the 16 cases observed
during an 11-week period thus represent an apparent out-
break.
In the present study, some observations are noteworthy.
However, the low number of cases does not allow any ﬁrm
conclusions to be drawn. The cases with NF and myositis
constituted half of the total invasive cases during the out-
break, more than twice the frequency at which they had
appeared in Norway during the previous three years (http://
www.msis.no).
Furthermore, the primary focus in four patients was in
the neck region, and two of the 16 patients had myositis. In
this study, the majority of patients (13 of 16) had C-reactive
protein >200 mg/L at admission. This is in accordance with
another Norwegian study of streptococcal soft tissue infec-
tions, and it may be helpful in identifying patients with inva-
sive streptococcal infection [10]. In our study, four of the 16
cases were caused by GGS, whereas in 1992–1999, only
4.6% (three of 65) NF cases were caused by GGS in our
hospital (A. Halstensen, personal communication). This coin-
cides with an increasing number of publications reporting
invasive GCS and GGS infections globally [11–15].
In the present study, the number of deaths among those
with GAS disease was one out of 11. All six patients with
NF survived, whereas two of the eight patients with STSS
and both patients with myositis died. Other studies have
reported a very high case-fatality rate associated with STSS
and myositis [22].
Penicillin and clindamycin are the recommended antibiotics
for the treatment of invasive GAS and GGS infections [23].
Some studies have indicated that clindamycin may be the
most important antibiotic in these cases [24,25]. In our
study, only one of the 11 patients who received clindamycin
died, whereas three of the ﬁve patients who did not receive
clindamycin died. However, the low number of patients, and
the fact that one of the patients who did not receive clinda-
mycin had an incurable malignancy contributing to early
death, does not allow conclusions to be drawn. In addition,
delay in surgery of more than 24 h has also been shown to
adversely affect the outcome of NF [26].
Well-established local routine procedures for diagnosis,
observation and early surgical exploration or debridement in
all patients with sepsis and soft tissue infections might have
contributed to recovery in our study, as similarly reported
elsewhere [26,27].
They also may have contributed to the low number of
patients with signiﬁcant coagulopathy or renal dysfunction.
Patients were not treated with intravenous immunoglobulin,
FIG. 2. Sequence analysis of the full-length emm amplicons of the four group G streptococcus (GGS) isolates. Reference emm sequences in Gen-
Bank with close homology to genes/gene segments of the analysed genes are shown above the lines representing emm genes. The percentage of
identity to these reference sequences, along with the homologous regions, deﬁned by the base numbers, are shown below the lines. GAS,
group A streptococcus.
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because of the lack of deﬁnitive data, especially for patients
who underwent early surgery and were treated with clinda-
mycin, in agreement with previous recommendations [23].
Several studies have shown that both advanced age and
comorbidities are risk factors for invasive GAS disease [3,4].
This seems to apply even more so for GGS infections
[12,14]. In the present study, predisposing factors were
found in 11 of the 16 patients including all of the GGS
cases.
The outbreak investigation could not establish any direct
link between the cases. It therefore appears unlikely that any
of the cases could have been prevented by public health
measures. No chemoprophylaxis was given, apart from treat-
ment with penicillin of three of the children associated with
case no. 1, who all had tonsillopharyngitis with GAS. Routine
use of chemoprophylaxis is not recommended in the guide-
lines of the Norwegian Institute of Public Health (http://
www.fhi.no). These guidelines and other recommendations
emphasize, rather, the importance of informing household
contacts about the clinical manifestations of invasive strepto-
coccal infection and of advising immediate medical attention
should these contacts develop such symptoms [28,29].
Molecular epidemiology
The identiﬁcation of nine different types among 13 patients
conﬁrmed the polyclonal nature of the outbreak. The emm
RFLP results correlated very well with the emm sequence
types among the GAS isolates, showing that it was a sufﬁ-
cient and sensitive alternative epidemiological tool, without
the need to resort to the more expensive and time-con-
suming sequence analysis. The sensitivity of emm RFLP
analysis could be further enhanced by using a panel of
restriction enzymes with different recognition sequences,
making this analysis useful in laboratories without sequenc-
ing facilities.
The identical results obtained from emm gene sequencing
and the whole genome analysis (PFGE) of the isolates at
different stages of illness from the same patient (case 1)
indicate either a re-infection or persistence in an intracellular
niche. The former possibility seems to be more likely, as
three daughters of this patient were treated for streptococ-
cal tonsillitis at the time of his second admission, indicating a
common source. Unfortunately, throat swabs for bacterial
culture were not obtained from the household members of
this patient prior to antibiotic treatment for bacterial charac-
terization.
Sequence analysis showed that all the amplicons were in
fact emm genes. The deduced protein structure indicated a
full-length a-coiled structure similar to that of M-protein
(PSIPRED, http://bioinf.cs.ucl.ac.uk/psipred, data not shown).
The observed recombinations did not result in either
truncation of the protein or change in its secondary struc-
ture. The primers used, with annealing sites that matched
the emm gene of GAS, also ampliﬁed this gene from GGS,
conﬁrming sequence identity at the annealing sites in GGS.
The ﬁnding that all GGS isolates had an emm gene is possibly
important for pathogenesis. Simpson et al. reported in 1987
that all GGS (n = 8) isolates from human infections pos-
sessed emm genes, whereas none of the 12 GGS isolates
from animals possessed such a gene. It was therefore pro-
posed that emm genes were critical for infection of the
human host [30]. Furthermore, they reported DNA homol-
ogy between the C-terminal region of the emm genes of the
human GGS isolates and a GAS isolate of M-type 12.
In their study, one of the GGS isolates had a nearly com-
plete duplication of the GAS emm12 gene, presumably
acquired from GAS. The present results support their ﬁnd-
ings. All of the human GGS isolates possessed emm genes.
emm sequence analysis suggested genetic transfer among
GAS and GGS, as seen in GGS isolate 15, which had seg-
ments of the emm genes from two different emm types of
GAS in the middle, ﬂanked by two different emm sequences
of GGS (Fig. 2). A further interesting feature is that the emm
gene of isolate 12 shows homology to the corresponding
gene of a GCS isolate, despite possessing a group G-speciﬁc
polysaccharide. The existence of the same emm types among
isolates with different group carbohydrate speciﬁcities has,
however, been previously documented [31–33]. Such ﬁndings
could also indicate horizontal transfer of emm genes between
GCS and GGS.
Horizontal genetic transfer among the different sero-
groups of b-haemolytic streptococci has also been reported
for housekeeping genes, superantigen genes, emm/emm-like
genes, and other virulence factors [32,34–43]. One report
describes a prophage-mediated transfer of genetic material
between GAS (M28 type) and group B streptococci [42].
Thus, such genetic transfers can result in very divergent
strains possessing identical M-speciﬁcities or different M-anti-
gens in otherwise identical strains. The role of the transfer
of virulence genes from GAS to GCS or GGS in the possible
emergence of the latter species as virulent pathogens is not
obvious [43,44]. Sequence analysis of the complete emm
gene also revealed many other features of interest among
the GAS isolates. As the C-terminal end is conserved among
many types, it came as no surprise that this region showed a
high degree of homology to many different emm types. This
region, however, is known to differ between the opacity fac-
tor-producing (OF+) and opacity factor-non-producing (OF))
types [45]. Consistent with this, the homology observed in
the study isolates was generally conﬁned to the types within
250 Clinical Microbiology and Infection, Volume 15 Number 3, March 2009 CMI
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15, 245–252
either the OF+ group or OF) group. It is noteworthy that
the emm gene of isolate 8 shows 100% identity to the genes
of a number of OF) strains at the C-terminal end, between
bases 651 and 881, but that, at the N-terminal end, between
bases 3 and 646, it is identical to emm75.0, which is OF+.
This ﬁnding is highly suggestive of a recombination between
an OF+ and an OF) strain. This could have possible implica-
tions for tissue tropism and pathogenesis, as OF) strains
have been classiﬁed as ‘rheumatogenic’, and OF+ strains as
‘nephrogenic’ and linked to skin infections.
To the best of our knowledge, this has not been reported
before. All the other GAS isolates that showed possible
recombinations (Isolates 1,2,4,9,10) were between emm
genes of the same OF category (Fig. 1).
Interchange of genetic material within and among the dif-
ferent groups of b-haemolytic streptococci seems to be a
dynamic process. The recent ﬁnding of such genetic transfer
at our hospital, coupled with that of the polyclonal nature of
the outbreak and the emergence of GGS as a pathogen caus-
ing invasive disease that is similar to disease caused by GAS,
is likely to have implications for bacterial survival and patho-
genesis.
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